Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Global Dental Biomaterials Market
The global dental biomaterials market is projected to expand from USD 10.97 billion in 2025 to USD 23.26 billion by 2035, reflecting a CAGR of 7.8%. Growth is driven by rising demand for aesthetic and restorative dental procedures, technological advancements in digital dentistry, and an aging global population. Key segments include metallic, ceramic, polymeric metal-ceramic, natural, and composite biomaterials, with applications spanning implantology, orthodontics, and prosthodontics.
End users such as dental hospitals, clinics, laboratories, and research institutes are central to market expansion. North America leads the market, while Asia-Pacific is anticipated to exhibit the fastest growth over the forecast period.
Market size
Growth trajectory through 2035
Global Dental Biomaterials Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 AI Integration in Dental Biomaterials
- Recent advancements in AI are transforming material selection, treatment planning, and procedural outcomes. AI algorithms analyze patient data to recommend optimal biomaterials for restorative and implant procedures, improving precision and reducing chair time.
-
Development 02 Bioceramic Innovations
- New bioceramic materials, such as bioactive glass and zirconia-reinforced composites, are gaining traction for their enhanced biocompatibility and regenerative properties. These materials are particularly valuable in implantology and periodontal regeneration.
-
Development 03
- 3D Printing Advancements: The adoption of 3D printing for dental biomaterials, including resins and ceramics, is accelerating. This technology enables rapid prototyping, customization, and cost-effective production of restorations and prosthetics.
-
Development 04 Sustainable Biomaterials
- Growing emphasis on sustainability is driving the development of eco-friendly biomaterials, such as biodegradable polymers and recycled metals. Companies are exploring alternatives to traditional materials to reduce environmental impact.
Emerging opportunities added
- Emerging Markets Expansion Rapid urbanization and rising disposable incomes in Asia-Pacific and Latin America present significant growth opportunities for dental biomaterials, particularly in implantology and orthodontics.
- Biomaterial Innovations Development of bioactive and biodegradable materials, as well as antimicrobial coatings, can address unmet clinical needs and expand application scope.
- AI and Automation Integration AI-driven material selection, treatment planning, and robotic-assisted procedures can enhance efficiency and outcomes, driving adoption of advanced biomaterials.
- Partnerships with Dental Service Organizations (DSOs) Collaborations with DSOs can streamline distribution and improve access to premium biomaterials in underserved regions.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $10.97 Bn
- CAGR
- 7.80%
- Expansion
- 2.1×
Market shape
top segment · 40.7% share
- Leading region
- North America
- Top end-user
- compatible materials
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High Cost of Advanced Biomaterials
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
AI Integration in Dental Biomaterials: Recent advancements in AI are transforming material selection, treatment planning, and procedural outcomes. AI algorithms analyze patient data to recommend optimal biomaterials for restorative and implant procedures, improving precision and reducing chair time
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 125-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Global Dental Biomaterials Market today ($10.97 Bn base), and how fast will it grow at 7.8% CAGR through 2035?
- Which of Ceramic:, derived hydroxyapatite, used in bone grafting and periodontal regeneration holds the largest share, and how do the growth rates diverge?
- How is demand distributed across term stability, friendly solutions, supported prostheses, emphasizing durability and natural aesthetics applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America, and MEA compare on market share and growth rate?
- Where do Dentsply Sirona, Align Technology, Envista Holdings and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Aging Population) and top restraints (led by High Cost of Advanced Biomaterials), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Aging Population The global increase in the geriatric population drives demand for restorative dental biomaterials, particularly for implantology and prosthodontics.
- Technological Advancements Innovations in CAD/CAM, 3D printing, and AI-driven diagnostics enhance precision, reduce procedural times, and improve patient outcomes in dental biomaterials applications.
- Rising Demand for Aesthetic Dentistry Growing patient preference for minimally invasive, natural-looking dental restorations fuels market growth in ceramic and composite biomaterials.
- Increased Dental Service Organizations (DSOs) Expansion of DSOs and dental service providers improves access to advanced dental care, particularly in North America and Europe.
- Digital Dentistry Adoption The integration of digital workflows in dental laboratories and clinics accelerates demand for compatible biomaterials, such as zirconia and resin composites.
Restraints
Holding it back
- High Cost of Advanced Biomaterials The premium pricing of ceramic, composite, and CAD/CAM-compatible materials limits adoption in price-sensitive markets, particularly in emerging economies.
- Regulatory and Compliance Hurdles Stringent approval processes for new biomaterials and devices extend time-to-market, delaying commercialization and adoption.
- Supply Chain Vulnerabilities Disruptions in the supply of critical raw materials, such as titanium and zirconia, pose risks to production and pricing stability.
- Limited Reimbursement Policies Insufficient insurance coverage for elective dental procedures, including cosmetic restorations, restricts market growth in certain regions.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging Population | +3.5% | Global | 2025–2035 |
| Technological Advancements | +2.2% | Global | 2025–2035 |
| Rising Demand for Aesthetic Dentistry | +1.7% | Global | 2025–2035 |
| Increased Dental Service Organizations (DSOs) | +1.2% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Cost of Advanced Biomaterials | −1.4% | Global | 2025–2029 |
| Regulatory and Compliance Hurdles | −0.9% | Global | 2025–2029 |
| Supply Chain Vulnerabilities | −0.7% | Global | 2025–2029 |
The dental biomaterials market is segmented by type, application, and end user, reflecting the diverse needs of the dental industry.
Revenue share by type · 2025 base year
% OF $10.97 BN GLOBAL DENTAL BIOMATERIALS MARKET · 4 TYPES COVERED
Each slice = that type's share of the total $10.97 Bn Global Dental Biomaterials Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Ceramic:
-
derived hydroxyapatite, used in bone grafting and periodontal regeneration
By application
-
term stability
-
friendly solutions
-
supported prostheses, emphasizing durability and natural aesthetics
By end-user industry
-
compatible materials
-
chart
-
template="hbar_progress" data
-
palette="muted_green">
-
size="15" fill="#0f172a" text
-
anchor="middle" font
-
weight="bold">Regional Coverage
-
size="11" fill="#334155" text
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $10.97 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~38.1% in 2025. Driven by manufacturing scale and end-market density.
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The dental biomaterials market is highly competitive, with a mix of multinational corporations, specialized manufacturers, and emerging players. The market is characterized by continuous innovation, strategic partnerships, and mergers and acquisitions to strengthen product portfolios and geographic presence.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Dentsply Sirona
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Align Technology
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Envista Holdings
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Straumann Group
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Henry Schein Dental
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Patterson Dental
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
3M Oral Care
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Ivoclar Vivadent AG
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• Who are the key players in the global dental biomaterials market?
Some key players operating in the global dental biomaterials market include 3M Company, Bego Medical GmbH, Carpenter Technology Corporation, Danaher Corporation, Datum Dental Ltd., GC Corporation, Henry Schein Inc., IvoclarVivadent AG, Keystone Dental Inc., Medtronic PLC. -
• What are the factors driving the global dental biomaterials market?
The need for dental biomaterials in the global market is being driven by factors including the ageing global population, an increase in dental implants, and an increase in dental problems. -
• How big is the global dental biomaterials market?
The global dental biomaterials market size was estimated at USD 7.52 billion in 2021 and is expected to reach USD 13.64 billion in 2029. -
• What is the global dental biomaterials market growth?
The global dental biomaterials market is expected to grow at a compound annual growth rate of 6.84% from 2022 to 2029 to reach USD 13.64 billion by 2029. -
• Which region accounted for the largest global dental biomaterials market share?
The North America dominated the global dental biomaterials market with a share of 38% in 2021.
The Global Dental Biomaterials Market is projected to reach $23.25 Bn by 2035, up from $10.97 Bn in 2025 — a 7.80% CAGR equating to roughly 2.1× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.